Methods of treatment using anti-IL-17A/F antibodies
US11492396B2 · kind B2 · utility
0Cited by
27References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2016 |
| Grant date | Nov 8, 2022 |
| Priority date | — |
| Expiry date | May 31, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to therapeutic uses of antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F in the treatment of dermatological and rheumatological diseases, such as psoriasis, psoriatic arthritis and axial spondyloarthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.